Figure 2.
Comprehensive phenotypic characterization of CD4+CD161+RholoT cells by multiparameter flow cytometry. PBMCs were stained with a panel of surface markers including monoclonal antibodies against CD16, TCR Vα24, CD8β, and γδ TCR to exclude natural killer, natural killer T, CD8dim, and γδ T cells, respectively. (A) Multiparameter analysis of gated CD4+CD161+ T cells revealed a mixture of effector (CD45RA−CD62L−CCR7−), central memory (CD45RA−CD62L+CCR7+), and naive-like (CD45RAintCD62L+ CCR7+) subsets; cumulative data from 5 independent experiments are shown. ***P < .001. (B) Contour plots showing expression of memory markers, CD45RO (left) and CD95 (right), on CD4+CD95neg, CD4+CD161+CD45RAint, and CD4+CD161+ T cells. (C) Regulatory T cells lack ABCB1 activity. Representative fluorescence-activated cell sorter (FACS) plots showing the frequency of CD25+Foxp3+ T cells (upper) in CD4+CD161+Rholo (left), CD4+CD161+Rhohi (middle), and CD4+CD161− (right) T cells; cumulative data from 9 independent experiments are shown in right lower panel. **P < .01; ****P < .0001. Histogram in lower left panel compares the mean fluorescence intensity (MFI) of CD127 among CD4+CD161+Rholo (red), CD4+CD161+Rhohi (blue), and CD4+CD161− (green) T-cell subsets. (D) Expression of c-kit and CD57 on CD4+CD161+Rhohi and CD4+CD161+Rholo T cells is mutually exclusive. Representative FACS plots show that c-kit expression is restricted to the rapidly effluxing CD4+CD161+ subset, whereas CD57 expression is restricted to the CD4+CD161+Rhohi T-cell subset with no detectable expression on CD4+CD161+Rholo T cells; cumulative data from 4 independent experiments are shown. **P < .01; ****P < .0001.